
    
      This study consists of two parts. In part-1, a single oral dose of ASP1941 or placebo is
      administered to healthy adult male subjects to investigate the safety, tolerability,
      pharmacokinetics and pharmacodynamics in healthy adult males. In part-2, ASP1941 or placebo
      are is administered by a multiple dose regimen.
    
  